73 investors have funded 21 Life Sciences companies head-officed in Denver, across 98 rounds (Mar 1999 – Nov 2025). They are ranked by how many Denver companies in this market they have actually backed.
"In Denver" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | CU Healthcare Innovation Fund | Aurora, United States | Series ASeries B | 2 | 3 | 1 | Apr 2023 | 18 |
| 2 | Foresite Capital | New York City, United States | Series BSeries CSeries D | 1 | 5 | 1 | Mar 2021 | 116 |
| 3 | Venrock | Palo Alto, United States | Series BSeries CSeries D | 1 | 4 | 2 | Nov 2019 | 346 |
| 4 | Paladin Capital | Washington, DC, United States | Series BSeries CSeries D | 1 | 4 | 3 | Nov 2019 | 99 |
| 5 | Malaysian Life Sciences Capital Fund | Kuala Lumpur, Malaysia | Series BSeries CSeries D | 1 | 4 | 1 | Nov 2019 | 15 |
| 6 | NanoDimension | Woodside, United States | Series BSeries C | 1 | 3 | 1 | Jan 2019 | 14 |
| 7 | Silverton Partners | Austin, United States | Seed | 1 | 2 | 1 | Apr 2025 | 94 |
| 8 | BVF Partners | San Francisco, United States | Post-IPO | 1 | 2 | 1 | Oct 2020 | 94 |
| 9 | Boulder Ventures | Boulder, United States | Series A | 1 | 2 | 2 | Nov 2023 | 46 |
| 10 | Merieux Equity Partners | Lyon, France | Series C | 1 | 2 | 2 | Jan 2019 | 36 |
| 11 | High Country Ventures | Boulder, United States | Series A | 1 | 2 | 2 | Apr 2016 | 19 |
| 12 | Cortado Ventures | Oklahoma City, United States | Series ASeed | 1 | 2 | — | May 2023 | 27 |
| 13 | Alchemy Capital Management | Mumbai, India | SeedSeries A | 1 | 2 | — | May 2023 | 12 |
| 14 | Merieux Developement | Lyon, France | Series CSeries D | 1 | 2 | — | Nov 2019 | 7 |
| 15 | Khosla Ventures | Menlo Park, United States | Seed | 1 | 1 | 1 | Jun 2020 | 680 |
| 16 | Fidelity Investments | Boston, United States | Series E+ | 1 | 1 | 1 | Mar 2021 | 358 |
| 17 | DCVC | Palo Alto, United States | Series A | 1 | 1 | — | Oct 2025 | 265 |
| 18 | Morgan Stanley | New York City, United States | Series E+ | 1 | 1 | — | Mar 2021 | 373 |
| 19 | Advantage Capital | New Orleans, United States | Series A | 1 | 1 | — | May 2023 | 296 |
| 20 | IndieBio | San Francisco, United States | Seed | 1 | 1 | 1 | Oct 2016 | 252 |
| 21 | Austin Ventures | Austin, United States | Series A | 1 | 1 | — | Mar 1999 | 153 |
| 22 | Blackbird Ventures | Surry Hills, Australia | Series A | 1 | 1 | — | Oct 2025 | 126 |
| 23 | Oak HC/FT | Stamford, United States | Series D | 1 | 1 | — | Nov 2019 | 105 |
| 24 | Morningside | Newton, United States | Series A | 1 | 1 | 1 | Jun 2019 | 101 |
| 25 | Citadel | Chicago, United States | Post-IPO | 1 | 1 | — | Oct 2020 | 99 |
| 26 | Lehman Brothers | New York City, United States | Series A | 1 | 1 | 1 | Oct 2002 | 69 |
| 27 | 7wire Ventures | Chicago, United States | Series B | 1 | 1 | — | Jul 2021 | 34 |
| 28 | Durable Capital Partners | Bethesda, United States | Series E+ | 1 | 1 | — | Mar 2021 | 50 |
| 29 | KdT Ventures | Black Mountain, United States | Series A | 1 | 1 | — | Oct 2025 | 44 |
| 30 | T1D Fund | Boston, United States | Series A | 1 | 1 | 1 | Jun 2019 | 34 |
| 31 | Mayo Clinic Business Accelerator | Rochester, United States | Series A | 1 | 1 | 1 | Feb 2020 | 38 |
| 32 | Radius Ventures | New York City, United States | Series A | 1 | 1 | — | Oct 2002 | 25 |
| 33 | Philips | Amsterdam, Netherlands | Series B | 1 | 1 | — | Jul 2021 | 36 |
| 34 | ND Capital | Woodside, United States | Series D | 1 | 1 | — | Nov 2019 | 20 |
| 35 | CAM Capital | New York City, United States | Post-IPO | 1 | 1 | — | Oct 2020 | 23 |
| 36 | JSCapital | Tel Aviv, Israel | Series E+ | 1 | 1 | — | Mar 2021 | 19 |
| 37 | First Trust Capital Partners | Wheaton, United States | Series A | 1 | 1 | — | Apr 2023 | 25 |
| 38 | ATP Private Equity Partners | Copenhagen, Denmark | PE | 1 | 1 | — | Jan 2011 | 28 |
| 39 | Lincoln Park Capital | Chicago, United States | Post-IPO | 1 | 1 | — | Jan 2018 | 23 |
| 40 | Chimera | Abu Dhabi, United Arab Emirates | Series B | 1 | 1 | 1 | Jul 2021 | 18 |
| 41 | Federated Hermes | Pittsburgh | Post-IPO | 1 | 1 | — | Oct 2020 | 17 |
| 42 | Rockies Venture Club | Denver, United States | Seed | 1 | 1 | 1 | Mar 2020 | 17 |
| 43 | Nelstone Ventures | New York City, United States | Series A | 1 | 1 | 1 | Apr 2019 | 17 |
| 44 | Triple Tree | Minneapolis, United States | Series B | 1 | 1 | — | Jul 2021 | 15 |
| 45 | GAN | Boulder | Seed | 1 | 1 | 1 | Mar 2021 | 14 |
| 46 | Align Ventures | New York City, United States | Seed | 1 | 1 | 1 | Mar 2021 | 10 |
| 47 | Roark Capital | Atlanta, United States | PE | 1 | 1 | — | Jan 2011 | 13 |
| 48 | SPRIM Global Investments | New York City, United States | Series A | 1 | 1 | 1 | Jan 2025 | 12 |
| 49 | Boyd Street Ventures | Norman, United States | Series A | 1 | 1 | — | May 2023 | 10 |
| 50 | Kickstart | Seed | 1 | 1 | — | Apr 2025 | 7 | |
| 51 | Saffron Hill Ventures | London, United Kingdom | Series A | 1 | 1 | — | Oct 2002 | 6 |
| 52 | UCHealth | Aurora, United States | Series B | 1 | 1 | — | Jul 2021 | 8 |
| 53 | AccelFoods | New York City, United States | Seed | 1 | 1 | 1 | Dec 2014 | 6 |
| 54 | EIC Rose Rock | Tulsa, United States | Series A | 1 | 1 | 1 | May 2023 | 7 |
| 55 | Spruce Capital Partners | San Francisco, United States | Series C | 1 | 1 | — | Feb 2018 | 5 |
| 56 | 46VC | Bentonville, United States | Series A | 1 | 1 | — | May 2023 | 6 |
| 57 | PIC Investment Group | Saskatoon, Canada | Seed | 1 | 1 | — | Jul 2018 | 5 |
| 58 | Anschutz Medical Campus | Aurora, United States | Series A | 1 | 1 | — | Jun 2019 | 4 |
| 59 | Bioventus | Durham, United States | Seed | 1 | 1 | — | Jun 2021 | 3 |
| 60 | Handok | Seoul, South Korea | Post-IPO | 1 | 1 | 1 | Jul 2019 | 4 |
| 61 | Pendrell | Kirkland, United States | Series B | 1 | 1 | — | Jul 2021 | 3 |
| 62 | Highpoint Ventures | Boulder, United States | Series A | 1 | 1 | — | Nov 2023 | 3 |
| 63 | Innosphere | Fort Collins, United States | Seed | 1 | 1 | 1 | Jan 2020 | 3 |
| 64 | Empire Capital Management | Norwalk, United States | Series A | 1 | 1 | — | Oct 2002 | 3 |
| 65 | Genexine | Seongnam-si, South Korea | Post-IPO | 1 | 1 | 1 | Jul 2019 | 2 |
| 66 | Copic | Minato City, Japan | Series A | 1 | 1 | 1 | Jul 2019 | 2 |
| 67 | Oasis Capital | Cambridge, United States | Seed | 1 | 1 | — | Dec 2021 | 2 |
| 68 | Axios | Arlington, United States | Series A | 1 | 1 | — | Oct 2025 | 2 |
| 69 | Fresenius Medical Care | Waltham, United States | Series B | 1 | 1 | — | Jul 2021 | 1 |
| 70 | Amerocap | New York City, United States | Seed | 1 | 1 | — | Dec 2021 | 1 |
| 71 | Tiger Aesthetics | Seed | 1 | 1 | — | Nov 2025 | 1 | |
| 72 | FortySix Venture Capital | Tulsa, United States | Seed | 1 | 1 | — | Dec 2021 | 1 |
| 73 | Spring St. Group | New York City, United States | Seed | 1 | 1 | 1 | Mar 2021 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Denver that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Inscripta inscripta.com |
14 | 31 | $2.5B | Series E+ Mar 2021 |
| Exum exuminstruments.com |
9 | 11 | $45M | Series A May 2023 |
| BioIntelliSense biointellisense.com |
8 | 8 | $360M | Series B Jul 2021 |
| Rezolute rezolutebio.com |
7 | 8 | $209.1M | Post-IPO Oct 2020 |
| ClinOne clinone.com |
5 | 7 | $16.6M | Series A Nov 2023 |
| Remedy Robotics remedyrobotics.com |
4 | 4 | $140M | Series A Oct 2025 |
| Health Language healthlanguage.com |
4 | 4 | $31.2M | Series A Oct 2002 |
| ImmunoMolecular Therapeutics imtherapeutics.com |
3 | 3 | $30M | Series A Jun 2019 |
| Even feeleven.com |
3 | 3 | $4.5M | Seed Mar 2021 |
| Vaporox vaporox.com |
3 | 3 | $1.5M | Seed Jun 2021 |
| Atkins atkins.com |
2 | 2 | $30M | PE Jan 2011 |
| Pluto Biosciences pluto.bio |
2 | 3 | $10.9M | Seed Apr 2025 |
| HeartHero hearthero.com |
2 | 2 | $250K | Series A Jul 2019 |
| RheumaGen rheumagen.com |
1 | 1 | $15M | Series A Jan 2025 |
| HumanCode humancode.com |
1 | 1 | $5M | Series A Mar 1999 |
| Covalent Data covalentdata.com |
1 | 2 | $3.7M | Series A Apr 2016 |
| Securisyn securisyn.com |
1 | 1 | $3.1M | Series A Feb 2020 |
| Kalot Superfood kalotsuperfood.com |
1 | 1 | $310K | Seed Dec 2014 |
| Pure Cultures purecultures.com |
1 | 1 | $250K | Seed Oct 2016 |
| GenesisTissue genesistissue.com |
1 | 1 | — | Seed Nov 2025 |
| VIRIS Detection Systems virisdetectionsystems.com |
1 | 1 | — | Seed Jun 2020 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Nov 2025 | Tiger Aesthetics | GenesisTissue | Seed | — |
| Oct 2025 | Axios | Remedy Robotics | Series A | $35M |
| Oct 2025 | DCVC | Remedy Robotics | Series A | $35M |
| Oct 2025 | Blackbird Ventures | Remedy Robotics | Series A | $35M |
| Oct 2025 | KdT Ventures | Remedy Robotics | Series A | $35M |
| Apr 2025 | Silverton Partners | Pluto Biosciences | Seed | $3.6M |
| Apr 2025 | Kickstart | Pluto Biosciences | Seed | $3.6M |
| Jan 2025 | SPRIM Global InvestmentsLED | RheumaGen | Series A | $15M |
| Nov 2023 | Boulder VenturesLED | ClinOne | Series A | $2M |
| Nov 2023 | Highpoint Ventures | ClinOne | Series A | $2M |
| May 2023 | Advantage Capital | Exum | Series A | $6M |
| May 2023 | Cortado Ventures | Exum | Series A | $6M |
| May 2023 | Boyd Street Ventures | Exum | Series A | $6M |
| May 2023 | Alchemy Capital | Exum | Series A | $6M |
| May 2023 | EIC Rose RockLED | Exum | Series A | $6M |
| May 2023 | 46VC | Exum | Series A | $6M |
| May 2023 | Silverton PartnersLED | Pluto Biosciences | Seed | $3.7M |
| Apr 2023 | Boulder VenturesLED | ClinOne | Series A | $3M |
| Apr 2023 | First Trust Capital Partners | ClinOne | Series A | $3M |
| Apr 2023 | CU Healthcare Innovation Fund | ClinOne | Series A | $3M |
Life Sciences investors in other cities
Other markets in Denver